(Q36119487)

12 August 2017

1 reference

title

Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy (English)

1 reference

12 August 2017

Thomas Pusl

1

1 reference

12 August 2017

Ulrich Beuers

series ordinal

2

1 reference

12 August 2017

publication date

1 April 2005

1 reference

Clinical Reviews in Allergy & Immunology

12 August 2017

published in

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

147-157

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:28:2:147

12 August 2017

exact match

0 references

cites work

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

1 reference

12 December 2020

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

12 December 2020

Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors

1 reference

12 December 2020

Treatment of pruritus of primary biliary cirrhosis with rifampin

1 reference

12 December 2020

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

12 December 2020

Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis

1 reference

12 December 2020

Induction of hepatic microsomal enzymes after brief administration of rifampicin in man

1 reference

12 December 2020

Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population

1 reference

12 December 2020

Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis

1 reference

12 December 2020

Primary biliary cirrhosis: new therapeutic directions

1 reference

12 December 2020

Lithocholate cholestasis--sulfated glycolithocholate-induced intrahepatic cholestasis in rats

1 reference

12 December 2020

Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

1 reference

12 December 2020

Raised histamine concentrations in chronic cholestatic liver disease

1 reference

12 December 2020

Osteoporosis: still a typical complication of primary biliary cirrhosis?

1 reference

12 December 2020

Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy X-ray absorptiometry

1 reference

12 December 2020

Managing patients suffering from acute and chronic fatigue

1 reference

12 December 2020

Central mu-opioid receptors are down-regulated in a rat model of cholestasis

1 reference

12 December 2020

Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment

1 reference

12 December 2020

Control of osteoclast differentiation

1 reference

12 December 2020

The experience of women with primary biliary cirrhosis: a literature review

1 reference

12 December 2020

Rifampin relieves pruritus in children with cholestatic liver disease

1 reference

12 December 2020

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

1 reference

12 December 2020

Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.

1 reference

12 December 2020

Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study.

1 reference

12 December 2020

Prediction of bone density from vitamin D receptor alleles

1 reference

12 December 2020

Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial.

1 reference

12 December 2020

The role of mast cell activation in cholestatic pruritus

1 reference

12 December 2020

Guidelines on the management of osteoporosis associated with chronic liver disease

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

1 reference

12 December 2020

Itching after epidural and spinal opiates

1 reference

12 December 2020

Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial

1 reference

12 December 2020

Sodium fluoride prevents bone loss in primary biliary cirrhosis

1 reference

12 December 2020

N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro

1 reference

12 December 2020

In situ detection of lipid peroxidation by-products in chronic liver diseases

1 reference

12 December 2020

Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry

1 reference

12 December 2020

Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

1 reference

12 December 2020

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

12 December 2020

Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys

1 reference

12 December 2020

Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy.

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia

1 reference

12 December 2020

N-acetylcysteine inhibits muscle fatigue in humans

1 reference

12 December 2020

Cholestatic liver diseases and health-related quality of life

1 reference

12 December 2020

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

12 December 2020

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

12 December 2020

Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy

1 reference

12 December 2020

The true impact of fatigue in primary biliary cirrhosis: a population study

1 reference

12 December 2020

Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats.

1 reference

12 December 2020

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists

1 reference

12 December 2020

Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis.

1 reference

12 December 2020

Does "hepatic osteodystrophy" differ from peri- and postmenopausal osteoporosis? A histomorphometric study

1 reference

12 December 2020

Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis

1 reference

12 December 2020

Genetic determinants of bone mass in adults. A twin study

1 reference

12 December 2020

Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice

1 reference

12 December 2020

Fatigue in chronic disease

1 reference

12 December 2020

Primary biliary cirrhosis: symptomatic treatment

1 reference

12 December 2020

Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

1 reference

12 December 2020

Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia

1 reference

12 December 2020

Failure of rifampin to relieve pruritus in chronic liver disease

1 reference

12 December 2020

Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis

1 reference

12 December 2020

A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid

1 reference

12 December 2020

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

1 reference

12 December 2020

Exercise-induced lipid peroxidation and leakage of enzymes before and after vitamin E supplementation

1 reference

12 December 2020

Ondansetron for pruritus due to cholestasis

1 reference

12 December 2020

Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver

1 reference

12 December 2020

Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis.

1 reference

12 December 2020

Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis

1 reference

12 December 2020

Augmented interleukin-1beta-induced depression of locomotor activity in cholestatic rats

1 reference

12 December 2020

Osteoporosis in primary biliary cirrhosis revisited

1 reference

12 December 2020

1 reference

12 December 2020

Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment

1 reference

12 December 2020

Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.

1 reference

12 December 2020

Bone loss and reduced osteoblast function in primary biliary cirrhosis

1 reference

12 December 2020

The pruritus of cholestasis: from bile acids to opiate agonists

1 reference

12 December 2020

Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Improvement of cholestatic pruritus by ondansetron

1 reference

12 December 2020

Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.

1 reference

12 December 2020

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial

1 reference

12 December 2020

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

1 reference

12 December 2020

Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis

1 reference

12 December 2020

Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis

1 reference

12 December 2020

Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial

1 reference

12 December 2020

Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis

1 reference

12 December 2020

Lack of osteomalacia in chronic cholestatic liver disease

1 reference

12 December 2020

Hepatic osteodystrophy.

1 reference

12 December 2020

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

12 December 2020

Cholestasis in the male rat is associated with naloxone-reversible antinociception

1 reference

12 December 2020

Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry

1 reference

12 December 2020

Fatigue in primary biliary cirrhosis

1 reference

12 December 2020

Understanding pruritus in systemic disease

1 reference

12 December 2020

Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone

1 reference

12 December 2020

Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis

1 reference

12 December 2020

Application of piezo film technology for the quantitative assessment of pruritus

1 reference

12 December 2020

[The treatment of primary biliary liver cirrhosis with rifampicin]

1 reference

12 December 2020

Quality of life before and after liver transplantation for cholestatic liver disease.

1 reference

12 December 2020

Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: a study by the use of in vivo microdialysis.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis

1 reference

12 December 2020

Primary biliary cirrhosis: new perspectives in diagnosis and treatment

1 reference

12 December 2020

Opioid peptides and primary biliary cirrhosis

1 reference

12 December 2020

The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids

1 reference

12 December 2020

Metabolic bone disease in primary biliary cirrhosis at presentation

1 reference

12 December 2020

Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study

1 reference

12 December 2020

Increased midbrain 5-HT1A receptor number and responsiveness in cholestatic rats

1 reference

12 December 2020

Pruritus in cholestasis: No direct causative role for bile acid retention

1 reference

12 December 2020

Osteoporosis in chronic cholestatic liver disease

1 reference

12 December 2020

Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis.

1 reference

12 December 2020

Effects of central administration of opioids on facial scratching in monkeys

1 reference

12 December 2020

Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1

1 reference

12 December 2020

The demography of primary biliary cirrhosis in Ontario, Canada

1 reference

12 December 2020

Pruritic effect of bile salts.

1 reference

12 December 2020

The pruritus of cholestasis

1 reference

12 December 2020

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study

1 reference

12 December 2020

Hormone replacement therapy and heart disease: replacing dogma with data

1 reference

12 December 2020

Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome

1 reference

12 December 2020

Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.

1 reference

12 December 2020

Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis

1 reference

12 December 2020

Endogenous opioids accumulate in plasma in a rat model of acute cholestasis

1 reference

12 December 2020

Review article: pruritus in cholestatic and other liver diseases

1 reference

12 December 2020

Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin.

1 reference

12 December 2020

Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

1 reference

12 December 2020

Clinical applications of visual analogue scales: a critical review.

1 reference

12 December 2020

Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation.

1 reference

12 December 2020

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.

1 reference

12 December 2020

Factors influencing the development of metabolic bone disease in primary biliary cirrhosis

1 reference

12 December 2020

Association of bone mineral density with polymorphism of the estrogen receptor gene

1 reference

12 December 2020

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis

1 reference

12 December 2020

Rifampicin-induced elevation of serum bile acids in man.

1 reference

12 December 2020

Primary biliary cirrhosis in men

1 reference

12 December 2020

Improved device for measuring scratching activity in patients with pruritus

1 reference

12 December 2020

A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease

1 reference

12 December 2020

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

12 December 2020

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

12 December 2020

Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC

1 reference

12 December 2020

Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis

1 reference

12 December 2020

Extrahepatic manifestations of cholestasis

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D

1 reference

12 December 2020

Serum levels of cytokines in chronic liver diseases

1 reference

12 December 2020

Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis

1 reference

12 December 2020

Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis

1 reference

12 December 2020

Low bone turnover state in primary biliary cirrhosis.

1 reference

12 December 2020

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

1 reference

12 December 2020

Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis

1 reference

12 December 2020

Serotonin and nociception

1 reference

12 December 2020

Pruritus and fatigue in primary biliary cirrhosis

1 reference

12 December 2020

Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat

1 reference

12 December 2020

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

12 December 2020

Update on primary biliary cirrhosis

1 reference

12 December 2020

Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications

1 reference

12 December 2020

The metabolic bone disease of primary sclerosing cholangitis

1 reference

12 December 2020

Hormone replacement therapy update: who should we be prescribing this to now?

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:28:2:147

1 reference

Dimensions Publication ID

12 August 2017

1043478443

0 references

1 reference